A promising new study has identified a highly accurate, non-invasive method to diagnose non-small cell lung cancer (NSCLC) ...

Aspyre Lung is a targeted biomarker panel of 114 genomic variants across 11 guideline-recommended genes with simultaneous DNA and RNA for non–small cell lung cancer (NSCLC). In this study, we ...

The technology helps doctors get clear information to make better decisions about treatment. By finding cancer sooner, LungLife AI aims to improve patient survival rates and overall health. This ...

A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer ...

Comparative analysis of immunotherapy treatments in non-small cell lung cancer (NSCLC) using novel causal machine learning approaches.

AI-augmented radiographic surveillance can help physicians “opportunistically detect” early signs of lung cancer, often prior to any symptoms appearing.

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a proposed collaboration with Guardant Health, I ...

Researchers say findings provide compelling evidence underscoring the potential of electric-field molecular fingerprinting for minimally invasive disease detection.

“This certainly changes things big time,” Dr. Vivek Yadav said. “Because approximately 50% of lung cancer is diagnosed when it’s already metastasized to different parts of the body and it ...

The researchers call this a "bio-AI hybrid" cancer screening approach . By using AI to assist cancer-sniffing dogs - which have long been utilized by various laboratories to detect disease - cancers ...